A fresh look at the freeze-all protocol: A SWOT analysis

Human Reproduction

Volumn 31, Issue 3, 2016, Pages 491-497

  Blockeel, Christophe ^a   Drakopoulos, Panagiotis ^a   Santos Ribeiro, Samuel ^a   Polyzos, Nikolaos P ^a   Tournaye, Herman ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

embryo cryopreservation; freeze all; GnRH agonist trigger; GnRH antagonist; IVF; ovarian stimulation; vitrification

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN;

ANALYSIS; ARTICLE; CLINICAL PROTOCOL; CRYOPRESERVATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FREEZING; FROZEN EMBRYO TRANSFER; INFERTILITY THERAPY; OOCYTE; OVARY HYPERSTIMULATION; STRENGTHS WEAKNESSES OPPORTUNITIES AND THREATS ANALYSIS; THAWING; VITRIFICATION; AGONISTS; ANTAGONISTS AND INHIBITORS; BIRTH RATE; EMBRYO CULTURE; EVALUATION STUDY; FEMALE; HUMAN; IN VITRO FERTILIZATION; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; RETROSPECTIVE STUDY;

BIRTH RATE; CLINICAL PROTOCOLS; CRYOPRESERVATION; EMBRYO CULTURE TECHNIQUES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84960089474     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev339     Document Type: Article

References (76)

1. AbdelHafez FF, Desai N, Abou-Setta AM, Falcone T, Goldfarb J. Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-Analysis. Reprod Biomed Online. 2010; 20: 209-222.
2. Acevedo B, Gomez-Palomares JL, Ricciarelli E, Hernandez ER. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril. 2006; 86: 1682-1687.
3. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Can fresh embryo transfers be replaced by cryopreserved-Thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Gen. 2010; 27: 357-363.
4. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril. 1997; 67: 917-922.
5. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2011; 5: CD001750.
6. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropinreleasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab. 2003; 88: 4186-4192.
7. Blockeel C, Engels S, DeVos M, Haentjens P, Polyzos NP, Stoop D, Camus M, Devroey P. Oestradiol valerate pretreatment in GnRH-Antagonist cycles: a randomized controlled trial. Reprod Biomed Online. 2012; 24: 272-280.
8. Bloise E, Feuer SK, Rinaudo PF. Comparative intrauterine development and placental function of ART concept: implications for human reproductive medicine and animal breeding. Hum Reprod Update. 2014; 20: 822-839.
9. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010; 25: 2092-2100.
10. Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003; 9: 515-522.
11. Casper RF. Introduction: gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization. Fertil Steril. 2015; 103: 865-866.
12. Cedrin-Durnerin I, Guivarc'h-Leveque A, Hugues JN, Groupe d'Etude en Medecine et Endocrinologie de la R. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial. Fertil Steril. 2012; 97: 1359-1364 e1351.
13. Chen H, Wang Y, Lyu Q, Ai A, Fu Y, Tian H, Cai R, Hong Q, Chen Q, Shoham Z et al. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles. Fertil Steril. 2015; 103: 1194-1201 e1192.
14. Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011; 26: 2593-2597.
15. Doody KJ. Cryopreservation and delayed embryo transfer-Assisted reproductive technology registry and reporting implications. Fertil Steril. 2014; 102: 27-31.
16. Eldar-Geva T, Zylber-Haran E, Babayof R, Halevy-Shalem T, Ben-Chetrit A, Tsafrir A, Varshaver I, Brooks B, Margalioth EJ. Similar outcome for cryopreserved embryo transfer following GnRH-Antagonist/GnRHagonist, GnRH-Antagonist/HCG or long protocol ovarian stimulation. Reprod Biomed Online. 2007; 14: 148-154.
17. El-Toukhy T, Taylor A, Khalaf Y, Al-Darazi K, Rowell P, Seed P, Braude P. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles A randomised study. Hum Reprod. 2004; 19: 874-879.
18. European, Middle East Orgalutran Study G. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod. 2001; 16: 644-651.
19. Evans J, Hannan NJ, Edgell TA, Vollenhoven BJ, Lutjen PJ, Osianlis T, Salamonsen LA, Rombauts LJ. Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence. Hum Reprod Update. 2014; 20: 808-821.
20. Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, Garcia-Velasco JA. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and 'freeze-All' approach in GnRH antagonist protocol. Fertil Steril. 2014; 101: 1008-1011.
21. Galindo A, Bodri D, Guillen JJ, Colodron M, Vernaeve V, Coll O. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol. 2009; 25: 60-66.
22. Garcia-Velasco JA, Fatemi H. To pill or not to pill in GnRH-Antagonist cycles: still an open debate. Reprod Biomed Online. 2015; 31: 445.
23. Ghobara T, Vandekerckhove P. Cycle regimens for frozen-Thawed embryo transfer. Cochrane Database Syst Rev. 2008; 23: CD003414.
24. Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived fromdonor oocytes. Cochrane Database Syst Rev. 2010; 20: CD006359.
25. Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-Analysis. Hum Reprod Update. 2006; 12: 159-168.
26. Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-Thawed embryo replacement cycles. Fertil Steril. 2007; 88: 616-621.
27. Griesinger G, Berndt H, Schultz L, Depenbusch M, Schultze-Mosgau A. Cumulative live birth rates after GnRH-Agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study. Eur J Obstet Gynecol Reprod Biol 2010a; 149: 190-194.
28. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-Analysis. Fertil Steril 2010b; 94: 2382-2384.
29. Groenewoud ER, Macklon NS, Cohlen BJ, Group Ats. Cryo-Thawed embryo transfer: natural versus artificial cycle A non-inferiority trial. (ANTARCTICA trial). BMC Women's Health. 2012; 12: 27.
30. Groenewoud ER, Cantineau AE, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-Thawed embryo transfer cycles? A systematic review and meta-Analysis. Hum Reprod Update. 2013; 19: 458-470.
31. Gurbuz AS, Gode F, Ozcimen N, Isik AZ. Gonadotrophin-releasing hormone agonist trigger and freeze-All strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases. Reprod Biomed Online. 2014; 29: 541-544.
32. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ. 2004; 328: 261.
33. Henningsen AK, Pinborg A, Lidegaard O, Vestergaard C, Forman JL, Andersen AN. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril. 2011; 95: 959-963.
34. Hernandez ER, Gomez-Palomares JL, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril. 2009; 91: 1358-1361.
35. Huang B, Hu D, Qian K, Ai J, Li Y, Jin L, Zhu G, Zhang H. Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy?. An analysis of more than 30 000 cycles. Fertil Steril. 2014; 102: 1345-1349.
36. Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grondahl ML, Westergaard L, Andersen CY. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2005; 20: 1213-1220.
37. Ishihara O, Kuwahara A, Saitoh H. Frozen-Thawed blastocyst transfer reduces ectopic pregnancy risk: an analysis of single embryo transfer cycles in Japan. Fertil Steril. 2011; 95: 1966-1969.
38. Ishihara O, Araki R, Kuwahara A, Itakura A, Saito H, Adamson GD. Impact of frozen-Thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277 042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril. 2014; 101: 128-133.
39. Itskovitz-Eldor J, Kol S, Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Hum Reprod. 2000; 15: 1965-1968.
40. Kalra SK, Ratcliffe SJ, Coutifaris C, Molinaro T, Barnhart KT. Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. Obstet Gynecol. 2011; 118: 863-871.
41. Kato O, Kawasaki N, Bodri D, Kuroda T, Kawachiya S, Kato K, Takehara Y. Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer. Eur J Obstet, Gynecol Reprod Biol. 2012; 161: 46-50.
42. Kawwass JF, Kissin DM, Kulkarni AD, Creanga AA, Session DR, Callaghan WM, Jamieson DJ, National ARTSSG. Safety of assisted reproductive technology in the United States, 2000-2011. JAMA. 2015; 313: 88-90.
43. Kol S, Humaidan P, Alsbjerg B, Engmann L, Benadiva C, Garcia-Velasco JA, Fatemi H, Andersen CY. The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors. Reprod Biomed Online. 2015; 30: 563-565.
44. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin release hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002; 78: 1025-1029.
45. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril. 2004; 82: 102-107.
46. Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, Griesinger G A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 2005a; 20: 2887-2892.
47. Kolibianakis EM, Tarlatzis B, Devroey P. GnRH antagonists in IVF. Reprod Biomed Online 2005b; 10: 705-712.
48. Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, Ai A, Shoham Z. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015; 104: 62-70 e63.
49. Ling LP, Phoon JW, Lau MS, Chan JK, Viardot-Foucault V, Tan TY, Nadarajah S, Tan HH. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-All strategy'. Reprod Biomed Online. 2014; 29: 392-394.
50. Lode H, Torres A, Cockle A. What drives our choices?. Evidence, guidelines or habit?. Int J Antimicrob Agents. 2007; 29(Suppl. 1): S17-S22.
51. Londra L, Moreau C, Strobino D, Garcia J, Zacur H, Zhao Y. Ectopic pregnancy after in vitro fertilization: differences between fresh and frozen-Thawed cycles. Fertil Steril. 2015; 104: 110-118.
52. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertility and Sterility. 2000; 73: 901-907.
53. Mochtar MH, Custers IM, Koks CA, Bernardus RE, Verhoeve HR, Mol BW, vanWely M, van der Veen F. Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial. Hum Reprod. 2011; 26: 1091-1096.
54. Opati P, Zheng R, Wang J, Xin Y, Zhao H, Bi D. Comparison of neonatal outcomes in macrosomic infants of diabetic and non-diabetic mothers. J Neonat Perinat Med. 2015; 8: 9-13.
55. Ozkaya E, San Roman G, Oktay K. Luteal phase GnRHa trigger in random start fertility preservation cycles. J Assist Reprod Gen. 2012; 29: 503-505.
56. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropinreleasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006; 85: 112-120.
57. Pelkonen S, Koivunen R, Gissler M, Nuojua-Huttunen S, Suikkari AM, Hyden-Granskog C, Martikainen H, Tiitinen A, Hartikainen AL. Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995-2006. Hum Reprod. 2010; 25: 914-923.
58. Pinborg A. To transfer fresh or thawed embryos?. Semin Reprod Med. 2012; 30: 230-235.
59. Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, Soderstrom-Anttila V, Nygren KG, Hazekamp J, Bergh C. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome?. Systematic review and meta-Analysis. Hum Reprod Update. 2013; 19: 87-104.
60. Pinborg A, Henningsen AA, Loft A, Malchau SS, Forman J, Andersen AN. Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?. Hum Reprod. 2014; 29: 618-627.
61. Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, Checa MA. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic reviewandmeta-Analysis. Fertil Steril. 2013; 99: 156-162.
62. Roque M, Valle M, Guimaraes F, Sampaio M, Geber S. Freeze-All policy: fresh vs. frozen-Thawed embryo transfer. Fertil Steril. 2015; 103: 1190-1193.
63. Santos-Ribeiro S, Polyzos NP, Stouffs K, De Vos M, Seneca S, Tournaye H, Blockeel C. Ovarian hyperstimulation syndrome after gonadotropinreleasing hormone agonist triggering and 'freeze-All': in-depth analysis of genetic predisposition. J Assist Reprod Genet. 2015; 32: 1063-1068.
64. Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C. Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod. 2012; 27: 1343-1350.
65. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles. Fertil Steril. 2007; 88: 237-239.
66. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-Thawed embryo transfers in high responders. Fertil Steril 2011a; 96: 516-518.
67. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-Thawed embryo transfer in normal responders. Fertil Steril 2011b; 96: 344-348.
68. Shapiro BS, Daneshmand ST, De Leon L, Garner FC, Aguirre M, Hudson C. Frozen-Thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy. Fertil Steril. 2012; 98: 1490-1494.
69. Sonmezer M, Turkcuoglu I, Coskun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011; 95: 2125 e2129-2111.
70. Tremellen KP, Lane M.Avoidance of weekend oocyte retrievals duringGnRH antagonist treatmentbysimple advancement ordelayofhCGadministration does not adversely affect IVF live birth outcomes. Hum Reprod. 2010; 25: 1219-1224.
71. Vandekerckhove F, Gerris J, Vansteelandt S, DeBaerdemaeker A, Tilleman K, De Sutter P. Delaying the oocyte maturation trigger by one day leads to a higher metaphase II oocyte yield in IVF/ICSI: a randomised controlled trial. Reprod Biol Endocrinol. 2014; 12: 31.
72. van de Vijver A, Polyzos NP, Van Landuyt L, De Vos M, Camus M, Stoop D, Tournaye H, Blockeel C. Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary?. Reprod Biomed Online. 2014; 29: 588-594.
73. Wennerholm UB, Henningsen AK, Romundstad LB, Bergh C, Pinborg A, Skjaerven R, Forman J, Gissler M, Nygren KG, Tiitinen A. Perinatal outcomes of children born after frozen-Thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod. 2013; 28: 2545-2553.
74. Wong KM, Mastenbroek S, Repping S. Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertil Steril. 2014; 102: 19-26.
75. Youssef M, van der Veen F, van Wely M. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod. 2010; 25: 559.
76. Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011; 19: CD008046.